School of Medicine


Showing 8,621-8,630 of 13,032 Results

  • Karen J. Parker, PhD

    Karen J. Parker, PhD

    Truong-Tan Broadcom Endowed Professor and Professor, by courtesy, of Comparative Medicine

    Current Research and Scholarly InterestsThe Parker Lab conducts research on the biology of social functioning in monkeys, typically developing humans, and patients with social difficulties.

  • Robertson Parkman

    Robertson Parkman

    Other Teaching Staff-Hourly, Pediatrics - Stem Cell Transplantation

    BioMy principal research interests have been the assessment of the immunological consequences of hematopoietic stem cell transplantation including both acute and chronic graft versus host disease and immune reconstitution and the use of hematopoietic stem cell transplantation to treat genetic diseases. My laboratory was the first to suggest that chronic graft versus host disease was an autoimmune disease directed at histocompatibility antigens shared by donors and recipients. The observation leaded to the assessment of the role of thymic dysfunction in the pathogenesis of chronic graft versus host disease. As a pediatric immunologist I have investigated the role of hematopoietic stem cell transplantation initially in the treatment of primary immune deficiency diseases and later the treatment of metabolic diseases, which lead to my involvement in the early gene transfer clinical trials.

  • Ugur Parlatan

    Ugur Parlatan

    Basic Life Research Scientist, Rad/Canary Center at Stanford for Cancer Early Detection

    BioDr. Ugur Parlatan is a Basic Life Research Scientist at the Canary Center at Stanford for Cancer Early Detection. Trained as a physicist, he leads photonics laboratory activities and develops optical spectroscopy and imaging approaches for molecular fingerprinting and characterization of extracellular vesicles (EVs). His work includes designing and optimizing measurement workflows, analyzing EV signatures from biomedical samples, and supporting disease-focused studies across cancer and metabolic conditions (including lung cancer, glioblastoma, pancreatic cancer, diabetes, and hepatotoxicity). He also mentors trainees (including NIH CREST program interns) and contributes to manuscripts and grant applications.

  • Gaurav Parmar, MD, MPH

    Gaurav Parmar, MD, MPH

    Candidate For Affiliation, Surgery

    BioDr. Gaurav Parmar is a vascular medicine specialist and Clinical Assistant Professor in the Division of Vascular Surgery at Stanford University School of Medicine. His clinical practice focuses on the comprehensive care of patients with arterial, venous, thrombotic, and aortic diseases, with particular expertise in peripheral artery disease, venous thromboembolism, thoracic aortic disease, vasculitis, fibromuscular dysplasia, arteriopathy, and advanced vascular imaging.

    Before joining Stanford, Dr. Parmar served on the faculty at Harvard Medical School and Massachusetts General Hospital, where he held several leadership roles, including Program Director of the Clinical Vascular Medicine Fellowship, Co-Medical Director of the Anticoagulation Management Service, and Medical Director of the Vascular Imaging Core Laboratory (VASCORE). Throughout his career, he has led multidisciplinary initiatives spanning clinical care, education, quality improvement, and clinical research, with a particular interest in building innovative vascular medicine programs that integrate patient care, advanced imaging, and clinical trials.

    Dr. Parmar's academic interests center on vascular disease, thrombosis, vascular imaging, and implementation of evidence-based therapies to improve patient outcomes. He has authored numerous peer-reviewed publications, book chapters, and invited reviews, and serves as an investigator and collaborator in multicenter clinical research. His work emphasizes translating emerging scientific evidence into practical strategies that improve the diagnosis and management of complex vascular disorders. An active educator and mentor, Dr. Parmar has developed educational programs for medical students, residents, fellows, and practicing clinicians, and is a frequent invited speaker at national and international scientific meetings. He is committed to advancing vascular medicine through multidisciplinary collaboration, innovation, and physician education.

    At Stanford, Dr. Parmar is focused on expanding comprehensive vascular medicine services, developing collaborative clinical and research programs across specialties, advancing vascular imaging and clinical trials, and training the next generation of leaders in vascular medicine. His overarching goal is to improve the care of patients with vascular disease through excellence in clinical practice, research, education, and program development.

  • Jane Parnes

    Jane Parnes

    Professor of Medicine, Emerita

    Current Research and Scholarly InterestsThe lab is studying the mechanisms controlling B cell responsiveness and the balance between tolerance and autoimmunity. B cells deficient in CD72 are hyperresponsive to stimulation through the B cell receptor. We are examining the alterations in B cell signaling in these B cells and the mechanisms by which CD72 deficiency partially abrogates anergic tolerance. We hope to learn how deficiency in CD72 leads to spontaneous autoimmunity and increased susceptibility to induced autoimmune disease.